MedAvail Holdings, Inc.
MDVLQ · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.01 | 0.09 | 0.10 |
| FCF Yield | -20.28% | -22.72% | -44.94% | -18.90% |
| EV / EBITDA | -2.02 | -0.56 | -2.15 | -4.80 |
| Quality | ||||
| ROIC | -17.16% | -16.26% | -38.51% | -26.40% |
| Gross Margin | 43.95% | 41.45% | -1.11% | -0.77% |
| Cash Conversion Ratio | 0.76 | 0.30 | 0.94 | 0.98 |
| Growth | ||||
| Revenue 3-Year CAGR | 2,877,813.87% | 3,258,928.15% | 3,506,255.80% | 3,392,241.47% |
| Free Cash Flow Growth | 14.46% | 51.57% | 8.07% | 11.89% |
| Safety | ||||
| Net Debt / EBITDA | 2.46 | 1.44 | 0.48 | 1.62 |
| Interest Coverage | -30.51 | -29.65 | -32.86 | -36.48 |
| Efficiency | ||||
| Inventory Turnover | 0.02 | 0.04 | 1.65 | 1.80 |
| Cash Conversion Cycle | 3,739.82 | 1,964.68 | 58.78 | 52.01 |